Medicines and Healthcare products Regulatory Agency (MHRA) Guidance producer subject to accreditation. Process subject to accreditation

Size: px
Start display at page:

Download "Medicines and Healthcare products Regulatory Agency (MHRA) Guidance producer subject to accreditation. Process subject to accreditation"

Transcription

1 Guidance producer subject to accreditation Process subject to accreditation Medicines and Healthcare products Regulatory Agency (MHRA) Device Bulletins Date: 18 June 2010 Draft Accreditation Report for consultation

2 Contents Introduction... 3 Accreditation recommendation... 3 Implementation... 4 Reapplication for accreditation... 5 Appendix A: NHS Evidence accreditation analysis... 7 Appendix B: Bibliography Appendix C: Advisory Committee members, external advisers and NHS Evidence accreditation team... 15

3 Introduction The NHS Evidence Accreditation Scheme recognises organisations that demonstrate high standards in producing health or social care guidance. Evidence users can therefore have high confidence in the quality of the information. Organisations can publicly display a seal of approval called an Accreditation Mark for three years after their processes have been accredited. The process for accrediting producers of guidance and recommendations for practice is described in the process manual 1. Accreditation recommendation It is proposed that the process to produce Device Bulletin (DB) guidance by the Medicines and Healthcare products Regulatory Agency (MHRA) Device Technology and Safety (DTS) Division is recommended for NHS Evidence accreditation. This draft decision is subject to public consultation before a final decision is made. Background to the guidance producer The MHRA was set up in April 2003 from a merger of the Medicines Control Agency and the Medical Devices Agency. The MHRA is an executive agency of the Department of Health (DH). The MHRA is the government agency responsible for ensuring that medicines and medical devices are effective and acceptably safe. The MHRA monitors the use of medicines and devices, and takes any necessary action to protect the public if there is a problem. The MHRA aims to make as much information as possible publicly available. Within the MHRA, the Device Technology and Safety (DT&S) division investigates adverse incidents involving medical devices reported by the NHS and private hospitals, C232A0-19B9-E0B5-D4A11FA899F4C219

4 care homes, manufacturers and directly from the public. Medical devices range from the most sophisticated diagnostic equipment used in hospitals, to simple bandages and other products sold over the counter to the public. Summary Device Bulletins provide safety information to medical device users, both professional and the public where applicable, to ensure they have the most up to date information. Device Bulletins contain guidance and information on aspects of general safe use and management of medical devices. They are written as a result of experience gained from adverse incident investigations, contacts with manufacturers and users, and other sources of information. The process used to produce Device Bulletins has a documented process for the evidence search that is fit for purpose and all evidence found is included for assessment. Suggestions to further strengthen the MHRA DT&S division development processes for Device Bulletins are: clarifying the role of lay members in the development process for Device Bulletins, including how the Public and patient engagement strategy is used clearly documenting, within the guidance, how the strength of the evidence base was assessed This draft decision is now going out for consultation, and the decision will be reviewed by the committee in the light of any feedback received before making a final recommendation. David Haslam Chair, Advisory Committee June 2010

5 Implementation If accreditation is awarded, guidance from the accredited producer will be identified on NHS Evidence by the Accreditation Mark. The accredited guidance producer is also granted a royalty-free, worldwide licence to use the NHS Evidence Accreditation Mark in accordance with the Conditions and Terms of Use 2. Providing these conditions are met, a guidance producer's accreditation will last for three years from publication of approval on the NHS Evidence website. Accredited guidance producers must take reasonable steps to ensure the accredited processes are followed when generating the type of evidence for which they are accredited. Accredited guidance producers should have quality assurance mechanisms in place and must inform NHS Evidence of any significant change to a process within 30 days. Figure: The NHS Evidence Accreditation Mark 2 D471CA81220F57DA

6 Reapplication for accreditation If accreditation is not granted, guidance from the non-accredited producer will still be available on the NHS Evidence site but will not be identified by the accreditation mark graphic. Guidance producers that are not accredited following the accreditation process have the opportunity to reapply from one year after the previous assessment. It is assumed that the organisation will have addressed any concerns highlighted in the original assessment before reapplying. The NHS Evidence team will provide detailed feedback and advice on areas where improvement is required to meet the criteria in a future application.

7 Appendix A: NHS Evidence accreditation analysis The Advisory Committee considered the following analysis of the guidance producer s compliance with NHS Evidence accreditation criteria, which covers six discrete domains. The full analysis leading to the accreditation decision is shown below. Domain Criterion Evidence for meeting the criterion Accreditation decision Does the guidance producer have a policy in place and adhered to that requires them to explicitly detail: 1.1 Overall objective The overall objective is Safeguarding public health and is documented on the front cover of all guidance documents reviewed. Scope and purpose 1.2 The clinical, healthcare or social questions covered In the case of Device Bulletins b-f the questions are safety based. All examples of guidance reviewed showed the safety questions as numbered sections in the body of the guidance documents. The questions are clearly indicated and, where applicable, explained. 1.3 Population and/or target audience to whom the guidance applies The Advisory Notice a section 2.2 states that inclusion of the target audience when drafting a proposal provides some evidence of need of the Device Bulletin. In the example guidance documents b-f, patient population can be inferred from the titles.

8 Domain Criterion Evidence for meeting the criterion Accreditation decision 1.4 Guidance includes clear recommendations in reference to specific clinical, healthcare or social circumstances The Advisory Notice a section 1 documents how the process of defining the information and considerations of specific sections take place. Evidence of this process in practice is clear in all of the examples of guidance b-f reviewed. Does the guidance producer have a policy in place and adhered to that means it includes: Stakeholder involvement 2.1 Individuals from all relevant stakeholder groups, including patient groups, in developing guidance 2.2 Patient and service user representatives and seeks patients views and preferences in developing guidance 2.3 Representative intended users in developing guidance. The composition of both the drafting group and the MHRA s Committee for the Safety of Devices (CSD) show that all relevant stakeholder groups are involved in developing guidance. The CSD includes patient representatives. Public and patient engagement strategy is available on the website which further seeks the views of patients and patient representatives. Section 2.4 of the Advisory Notice a specifies that the review group should always include a typical reader. In addition the Advisory Notice also states that any relevant professional bodies should be included in the review process. Rigour of Does the guidance producer have a clear policy in place that:

9 Domain Criterion Evidence for meeting the criterion Accreditation decision development 3.1 Requires the guidance producer to use systematic methods to search for evidence and provide details of the search strategy 3.2 Requires the guidance producers to state the criteria and reasons for inclusion or exclusion of evidence identified by the evidence review 3.3 Describes the strengths and limitations of the body of evidence and acknowledges any areas of uncertainty Typical evidence searched includes trends in medical device incidents reported to MHRA (via adverse incidents tracking database) and data from registries or clinical studies. Systematic methods are used to search for evidence on which the Device Bulletin is based. No evidence is excluded from searches to produce a Device Bulletin,. All information found by the search strategy is included. The adverse incidents reports database is searched to provide the evidence base for the Device Bulletins. All of the information found during a specific search is used and no weighting is applied, which is fit for purposed for this type of guidance product. 3.4 Describes the method used to arrive at recommendations (for example, a voting system or formal consensus techniques like Delphi consensus) The process for the production of Device Bulletins is an authorship process, and therefore no voting occurs. However the guidance development process contains a clear description of the method used to develop recommendations.

10 Domain Criterion Evidence for meeting the criterion Accreditation decision 3.5 Requires the guidance producers to consider the health benefits against the side effects and risks in formulating recommendations This is the overall objective of the MHRA and the balance between risks and benefits is shown in the Aims and objectives section of their website. The principal aim of the guidance product is to balance health benefits against risks by providing healthcare professionals with up-to-date medical device safety information so that they can make informed choices. 3.6 Describes the processes of external peer review Section 2.4 and 4.3 of the Advisory Notice a outlines the process for external peer review of Device Bulletins. 3.7 Describes the process of updating guidance and maintaining and improving guidance quality Device Bulletins provide safety advice driven by new findings regarding possible safety issues for medical devices. Rather than being date driven the guidance is data driven so no regular updating schedule is available. Furthermore, the guidance itself is an update that may contain important ancillary information which is provided in addition to that produced when the medical device is licensed for production. Does the guidance producer ensure that: Clarity and presentation 4.1 Recommendations are specific, unambiguous and clearly identifiable Device Bulletins provide advice on the safe use of medical devices and additional up-to-date safety information to medical device users. The safety recommendations are specific, unambiguous and clearly shown within the Device Bulletins.

11 Domain Criterion Evidence for meeting the criterion Accreditation decision 4.2 Different options for the management of the condition or options for intervention are clearly presented 4.3 The date of search, the date of publication or last update and the proposed date for review are clearly stated This criterion is not applicable because Device Bulletin advise on the safe use of specific devices, not the management of conditions.. All example guidance b-f reviewed bears the date of publication and date of update where applicable. The date of literature search cannot be found. The guidance is eventrather than date-led since the updates are driven by new evidence so review dates are not applicable (see also criterion 3.1). Not applicable 4.4 The content of the guidance is suitable for the specified target audience. If patients or service users are part of this audience, the language should be appropriate. The guidance examples b-f reviewed are suitable for all audiences. Any technical terms are explained and ideas are described so the reader can understand the options (where applicable), recommendations and the evidence behind them. Does the guidance producer routinely consider: Applicability 5.1 Publishing support tools to aid implementation of guidance An alert process ensures that this guidance reaches its target audience. Since the guidance is a dissemination of safety information from the MHRA s DT&S division it describes how to use a medical device with a revised safety review and is considered obligatory.

12 Domain Criterion Evidence for meeting the criterion Accreditation decision 5.2 Discussion of potential organisational and financial barriers in applying its recommendations 5.3 That their guidance is current, with review criteria for monitoring and/or audit purposes within each product This criterion is not applicable because external organisations must overcome financial and organisational barriers to implement the guidance for safe use of medical devices. This criterion is not applicable for this type of guidance product. A date of publication is stated but no evidence of a process for review criteria, audit or information about monitoring is provided (see criterion 5.2). It would not be productive to measure compliance with only those aspects of safety Not applicable Not applicable contained within the guidance b-f. Does the guidance producer: 6.1 Ensure editorial independence from the funding body Section 5 MHRA framework document details the process of how the funding is collated and disseminated. In addition to the dispersed funding mechanism, the guidance is developed via a number of multidisciplinary Editorial groups, such as the CSD and it is peer reviewed. independence 6.2 Demonstrate transparency about the funding mechanisms for its guidance The MHRA is an executive agency of the DH with trading fund status. The agency is funded by fees charged for fulfilment of statutory obligations, charges for non-statutory services and the DH. Section 5 (Finance) of the MHRA framework document describes how the MHRA generates and disseminates its finances and explains its accounting and auditing arrangements.

13 Domain Criterion Evidence for meeting the criterion Accreditation decision 6.3 Record and state any potential conflicts of interest of individuals involved in developing the recommendations 6.4 Take account of any potential for bias in the conclusions or recommendations of the guidance Section 7.14 of the MHRA framework document states that all MHRA employees are required to state any potential conflicts of interest. Any declarations of interests are published on the website. A combination of conflict of interest declarations, guidance decisions determined by multidisciplinary groups, peer review and transparency in the way the work is funded ensures this criterion is satisfied. The webpage What principles inform the decisions? point 10 also documents the agency s decisions will as far as possible be transparent and open to public scrutiny; a reasonable person reviewing our decisions should understand the rationale. a Advisory Notice Drafting and publishing a device bulletin, 2002 (process manual). b DB2009 (02) Adverse incident reports 2008 c DB2008 (04) In vitro diagnostic medical devices used in combination d DB2008 (03) Guidance on the safe use of lasers, intense light source systems and LEDs in medical, surgical and aesthetic practises e DB2009 (01) Reporting adverse incidents and disseminating medical device alerts f DB2007 (03) Safety guidelines for magnetic resonance imaging equipment in clinical use.

14 Appendix B: Bibliography Appendix B lists the additional information taken into account in the analysis and considered by the Committee. Document name Description Location DB2009 (02) Adverse Example guidance incident reports 2008 supplied by guidance producer DB2008 (04) In vitro Example guidance diagnostic medical devices supplied by guidance used in combination producer DB2008 (03) Guidance on Example guidance the safe use of lasers, supplied by guidance intense light source producer systems and LED s in medical, surgical and aesthetic practises. guidance/devicebulletins/con guidance/devicebulletins/con guidance/devicebulletins/con DB2009 (01) Reporting Adverse incidents and disseminating Medical Device Alerts DB2007 (03) Safety Guidelines for Magnetic Resonance Imaging Equipment in Clinical Use ADVISORY NOTICES: Drafting and publishing a Device Bulletin MHRA Framework document Example guidance chosen arbitrarily to validate the application of processes Example guidance chosen arbitrarily to validate the application of processes Drafting Device Bulletins procedure Document outlining the MHRA framework guidance/devicebulletins/con guidance/devicebulletins/con Drafting Device Bulletins procedure Searchresults/CON008369

15 Appendix C: Advisory Committee members, external advisers and NHS Evidence accreditation team NHS Evidence Advisory Committee Members The NHS Evidence Advisory Committee operates as a standing advisory committee of the Board of the National Institute for Health and Clinical Excellence (NICE). The Committee provides advice to the Institute on a framework for accrediting sources of evidence that should be recognised as trusted sources of information for the NHS. The Chair of the Committee is appointed by the Institute s Board and the meetings are conducted by the Chair or in his/her absence the vice chair. The current Chair is David Haslam. A full list of the Advisory Committee membership is available on the NICE website 3. The members have been appointed for a period of 18 months. This may be extended by mutual agreement to a further term of 3 years and up to a maximum term of office of 10 years. The decisions of the Committee are arrived at by a consensus of those members present. The quorum is set at 50% of committee membership. The Committee submits its recommendations to the Institute s Guidance executive which acts under delegated powers of the Institute s Board in considering and approving its recommendations. Committee members are asked to declare any interests in the guidance producer to be accredited. If it is considered that there is a conflict of interest, the member(s) is excluded from participating further in the discussions. A list of the committee members who took part in the discussions for this accreditation decision appears below. Title Name Surname Role Organisation Ms Judy Birch Lay member 3 Medicines and Healthcare products Regulatory Agency: Device Technology and Safety Division; Device Bulletins: Draft Accreditation Report Page 15 of 17

16 Mr Richard Brownhill Clinical Development & Nurse practitioner Calderdale and Huddersfield NHS Trust and Kirklees PCT Ms Amanda Edwards Head of Knowledge Services Social Care Institute for Excellence (SCIE) Ms Joyce Epstein Lay member Dr Brian Fisher General Practitioner NHS Alliance (GP and national patient/public lead) Professor David Haslam National Clinical Advisor Care Quality Commission Dr Bobbie Jacobson Dr Monica Lakhanpaul Professor Stuart Logan Dr Donal O Donoghue Professor Sandy Oliver Dr Mahendra Patel Director of London Health Observatory, Vice Chair of Association of PH Observatories Senior Lecturer / Consultant Paediatrician / Clinical Director Professor of Paediatric Epidemiology National Clinical Director for Kidney Care and consultant renal physician Professor of Public Policy, Deputy Director, Social Science Research Unit Senior lecturer in pharmacy practice, school of applied sciences/consultant Pharmacist London Health Observatory Health Education Research and Development Unit (HERADU), Department of Medical Education and Social Care, University of Leicester Peninsula College of Medicine and Dentistry Salford Royal NHS Foundation Trust Cochrane Consumers and Communication Review Group, University of London University of Huddersfield Mr Adrian Reyes- Hughes Associate Clinical Director NHS Direct Dr Karen Ritchie Ms Sasha Shepperd Dr Mark Strong Lead Health Services Researcher Senior Research Scientist, Department of Public Health MRC Fellow, Section of Public Health NHS Quality Improvement Scotland University of Oxford School of Health and Related Research (ScHARR) Medicines and Healthcare products Regulatory Agency: Device Technology and Safety Division; Device Bulletins: Draft Accreditation Report Page 16 of 17

17 University of Sheffield Ms Gill Swash Head of knowledge and Library Services NHS Western Cheshire Dr Sara Twaddle Director Scottish Intercollegiate Guidelines Network Advisory Committee Deputies Title Name Surname Role Organisation Deputising for Ms Lynda Cox Head of Knowledge Sharing and Learning North East Strategic Health Authority Stephen Singleton External Advisers for MHRA Device Technology and Safety Division Device Bulletins accreditation application Aideen Mary Tarpey, Epilepsy Specialist Nurse - Dorset, Poole Hospital NHS Foundation Trust, Poole, Dorset, UK Dr Timothy E Bates, Chief Scientific Officer, New-Use Therapeutics Limited, Nottingham, UK NHS Evidence accreditation team for MHRA Device Technology and Safety Division Device Bulletins accreditation application Stephanie Birtles, Accreditation Technical Analyst, NHS Evidence, National Institute for Health and Clinical Excellence, Manchester, UK Dr Paul Chrisp, Associate Director Accreditation, NHS Evidence, National Institute for Health and Clinical Excellence, Manchester, UK Medicines and Healthcare products Regulatory Agency: Device Technology and Safety Division; Device Bulletins: Draft Accreditation Report Page 17 of 17

Final Accreditation Report

Final Accreditation Report Guidance producer: Medicines and Healthcare products Regulatory Agency (MHRA) Guidance product: Device Bulletins Date: 20 September 2010 Final Accreditation Report Page 1 of 21 Contents Introduction...

More information

Medicines and Healthcare products Regulatory Agency (MHRA) Guidance producer subject to accreditation. Process subject to accreditation

Medicines and Healthcare products Regulatory Agency (MHRA) Guidance producer subject to accreditation. Process subject to accreditation Guidance producer subject to accreditation Process subject to accreditation Medicines and Healthcare products Regulatory Agency (MHRA) Pharmacovigilance Public Assessment Reports Date: 18 June 2010 Draft

More information

Medicines and Healthcare products Regulatory Agency (MHRA) Public Assessment Reports

Medicines and Healthcare products Regulatory Agency (MHRA) Public Assessment Reports Guidance producer: Medicines and Healthcare products Regulatory Agency (MHRA) Guidance product: Public Assessment Reports Date: 18 June 2010 Version: 1.4 Draft Accreditation Report for consultation Medicines

More information

Final Accreditation Report

Final Accreditation Report Guidance producer: Royal College of Surgeons of England: Surgical Specialty Associations Guidance product: Clinical Commissioning Guides Date: 28 February 2013 Version: 1.3 Final Accreditation Report Royal

More information

Egton Medical Information Systems Limited (EMIS) Clinical Immediate Reference articles

Egton Medical Information Systems Limited (EMIS) Clinical Immediate Reference articles Guidance producer: Egton Medical Information Systems Limited (EMIS) Guidance product: Clinical Immediate Reference articles Date: 17 August 2010 Final Accreditation Report Contents Introduction... 3 Accreditation

More information

Final Accreditation Report

Final Accreditation Report Guidance producer: Resuscitation Council (UK) Guidance product: 2010 resuscitation guidelines Date: 2 August 2012 Version: 1.4 Final Accreditation Report Page 1 of 19 Contents Introduction... 3 Accreditation

More information

Final Accreditation Report

Final Accreditation Report Guidance producer: Healthcare Infection Society Guidance product: Clinical Guidelines Date: 23 March 2015 Version: 1.6 Final Accreditation Report Page 1 of 19 Contents Introduction... 3 Accreditation recommendation...

More information

Clinical guideline for the prevention and treatment of osteoporosis

Clinical guideline for the prevention and treatment of osteoporosis Guidance producer: National Osteoporosis Guideline Group Guidance product: Clinical guideline for the prevention and treatment of osteoporosis Date: 9 March 2017 Version: 1.3 Final Accreditation Report

More information

The Renal Association

The Renal Association Guidance producer: The Renal Association Guidance product: Clinical Practice Guidelines Date: 11 January 2017 Version: 1.4 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation...

More information

Draft Accreditation Report for consultation

Draft Accreditation Report for consultation Guidance producer: Guidance product: NHS Fetal Anomaly Screening Programme (FASP) UK National Screening Committee (NSC) NHS Fetal Anomaly Screening Programme Screening for Down s syndrome: UK NSC Policy

More information

British Association of Dermatologists

British Association of Dermatologists Guidance producer: British Association of Dermatologists Guidance product: Service Guidance and Standards Date: 13 March 2017 Version: 1.2 Final Accreditation Report Page 1 of 26 Contents Introduction...

More information

Final Accreditation Report

Final Accreditation Report Guidance producer: British National Formulary Publications Guidance product: Nurse Prescribers Formulary Date: 10 March 2014 Final Accreditation Report Page 1 of 28 Contents Introduction... 3 Accreditation

More information

Final Accreditation Report

Final Accreditation Report Guidance producer: The Royal College of Physicians of London Guidance product: National Clinical Guideline for Stroke Date: 19 September 2016 Version: 1.2 Final Accreditation Report Report Page 1 of 21

More information

Final Accreditation Report - for guidance and advice for use in decision support systems

Final Accreditation Report - for guidance and advice for use in decision support systems Guidance producer: NHS Direct Guidance product: The content of the Call Streaming Prioritisation Tool and Teleguides Date: 2 January 2013 Version: 1.4 Final Accreditation Report - for guidance and advice

More information

Accreditation Decision Report for consultation

Accreditation Decision Report for consultation Guidance producer: British National Formulary Publications Guidance product: British National Formulary, British National Formulary for Children Date: 29 August 2013 Version: 1.4 Accreditation Decision

More information

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

British Society for Surgery of the Hand. (BSSH) Evidence for Surgical

British Society for Surgery of the Hand. (BSSH) Evidence for Surgical British Society for Surgery of the Hand (BSSH) Evidence for Surgical Treatment (B.E.S.T.) Process Manual 1 st Edition (12 th version, November 2016) Review Date: November 2019 BSSH Evidence for Surgical

More information

Clinical Practice Guideline Development Manual

Clinical Practice Guideline Development Manual Clinical Practice Guideline Development Manual Publication Date: September 2016 Review Date: September 2021 Table of Contents 1. Background... 3 2. NICE accreditation... 3 3. Patient Involvement... 3 4.

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,

More information

How NICE clinical guidelines are developed

How NICE clinical guidelines are developed Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition

More information

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the

More information

NHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence

NHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development

More information

Draft National Quality Assurance Criteria for Clinical Guidelines

Draft National Quality Assurance Criteria for Clinical Guidelines Draft National Quality Assurance Criteria for Clinical Guidelines Consultation document July 2011 1 About the The is the independent Authority established to drive continuous improvement in Ireland s health

More information

QUALITY COMMITTEE. Terms of Reference

QUALITY COMMITTEE. Terms of Reference QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Quality Committee (known as the Committee in these terms of reference) for the purpose of:

More information

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications European Reference Networks Guidance on the recognition of Healthcare Providers and UK Oversight of Applications NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients

More information

Initial education and training of pharmacy technicians: draft evidence framework

Initial education and training of pharmacy technicians: draft evidence framework Initial education and training of pharmacy technicians: draft evidence framework October 2017 About this document This document should be read alongside the standards for the initial education and training

More information

Vaccine uptake in under 19s (quality standard) Stakeholders Action on Smoking & Health (ASH) Advertising Standards Authority Advertising Standards

Vaccine uptake in under 19s (quality standard) Stakeholders Action on Smoking & Health (ASH) Advertising Standards Authority Advertising Standards Vaccine uptake in under 19s (quality standard) Stakeholders Action on Smoking & Health (ASH) Advertising Standards Authority Advertising Standards Authority (ASA) Alcohol Concern Anglian Community Enterprise

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide

More information

CLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final

CLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as

More information

European network of paediatric research (EnprEMA)

European network of paediatric research (EnprEMA) 17 February 2012 EMA/77450/2012 Human Medicines Development and Evaluation Recognition criteria for self assessment The European Medicines Agency is tasked with developing a European paediatric network

More information

Independent prescribing conversion programme. De Montfort University Report of a reaccreditation event May 2017

Independent prescribing conversion programme. De Montfort University Report of a reaccreditation event May 2017 Independent prescribing conversion programme De Montfort University Report of a reaccreditation event May 2017 GPhC, independent prescribing conversion programme reaccreditation report Page 1 of 10 Event

More information

Public Health Skills and Career Framework Multidisciplinary/multi-agency/multi-professional. April 2008 (updated March 2009)

Public Health Skills and Career Framework Multidisciplinary/multi-agency/multi-professional. April 2008 (updated March 2009) Public Health Skills and Multidisciplinary/multi-agency/multi-professional April 2008 (updated March 2009) Welcome to the Public Health Skills and I am delighted to launch the UK-wide Public Health Skills

More information

CCG Policy for Working with the Pharmaceutical Industry

CCG Policy for Working with the Pharmaceutical Industry CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry

More information

CORRESPONDING AUTHOR:

CORRESPONDING AUTHOR: TITLE: A paediatrician s guide to Clinical Trials Units AUTHORS: Chris Gale, Edmund Juszczak CORRESPONDING AUTHOR: Dr C Gale, NIHR Clinical Trials Fellow, Imperial Clinical Trials Unit and section of Neonatal

More information

Maximising the impact of nursing research. RCN research conference 5-7 April 2017, Oxford, UK

Maximising the impact of nursing research. RCN research conference 5-7 April 2017, Oxford, UK Maximising the impact of nursing research RCN research conference 5-7 April 2017, Oxford, UK Paper 1 Maximising the Impact of nursing research through collaboration Professor Daniel Kelly, RCN Professor

More information

abcdefghijklmnopqrstu

abcdefghijklmnopqrstu Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy

More information

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with

More information

Central Alerting System (CAS) Policy

Central Alerting System (CAS) Policy Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM (PACS) TIER 2

5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM (PACS) TIER 2 NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 5: NON-FORMULARY PROCESSES 5.3: POLICY FOR THE MANAGEMENT OF REQUESTS FOR MEDICINES VIA PEER APPROVED CLINICAL SYSTEM

More information

PROGRAMME SPECIFICATION(POSTGRADUATE) 1. INTENDED AWARD 2. Award 3. Title 28-APR NOV-17 4

PROGRAMME SPECIFICATION(POSTGRADUATE) 1. INTENDED AWARD 2. Award 3. Title 28-APR NOV-17 4 Status Approved PROGRAMME SPECIFICATION(POSTGRADUATE) 1. INTENDED AWARD 2. Award 3. MSc Surgical Care Practice (Trauma & Orthopaedics) 4. DATE OF VALIDATION Date of most recent modification (Faculty/ADQU

More information

ERN Assessment Manual for Applicants

ERN Assessment Manual for Applicants Share. Care. Cure. ERN Assessment Manual for Applicants 3.- Operational Criteria for the Assessment of Networks An initiative of the Version 1.1 April 2016 History of changes Version Date Change Page 1.0

More information

Policy for the Sponsorship of Activities and Joint Working with the Pharmaceutical Industry

Policy for the Sponsorship of Activities and Joint Working with the Pharmaceutical Industry Policy for the Sponsorship of Activities and Joint Working with the Pharmaceutical Industry March 2017 NOTE: This policy will be subject to review in 2017/18 as part of the partnership work between North

More information

Supporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014

Supporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014 Supporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction

More information

Supporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013

Supporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013 Supporting information for appraisal and revalidation: guidance for Occupational Medicine, April 2013 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction

More information

NICE Charter Who we are and what we do

NICE Charter Who we are and what we do NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and

More information

Standards for Registered Pharmacies

Standards for Registered Pharmacies Council meeting 13 September 2012 Public business Standards for Registered Pharmacies Purpose This paper seeks the Council s approval of the standards for registered pharmacies. The Council is asked to

More information

Consultation on initial education and training standards for pharmacy technicians. December 2016

Consultation on initial education and training standards for pharmacy technicians. December 2016 Consultation on initial education and training standards for pharmacy technicians December 2016 The text of this document (but not the logo and branding) may be reproduced free of charge in any format

More information

MHRA response to the Independent Review on access to clinical advice and engagement with the clinical community in relation to medical devices

MHRA response to the Independent Review on access to clinical advice and engagement with the clinical community in relation to medical devices MHRA response to the Independent Review on access to clinical advice and engagement with the clinical community in relation to medical devices The MHRA warmly welcomes the independent report Expert Clinical

More information

Membership of Oral health for adults in care homes public health advisory committee

Membership of Oral health for adults in care homes public health advisory committee Committee membership list Oral health for adults in care homes guideline Committee Membership of Oral health for adults in care homes public health advisory committee The Committee will operate as an advisory

More information

CLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference

CLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference CLINICAL GOVERNANCE AND QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as the Committee in

More information

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) 31 January 2013 1 EUCERD RECOMMENDATIONS ON RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) INTRODUCTION 1. BACKGROUND TO

More information

WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0

WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review

More information

NHS QIS & NICE Advice. defi nitions & status

NHS QIS & NICE Advice. defi nitions & status NHS QIS & NICE Advice defi nitions & status NHS Quality Improvement Scotland 2006 First published August 2006 You can copy or reproduce the information in this document for use within NHSScotland and for

More information

North East Hampshire and Farnham Clinical Commissioning Group Safeguarding Framework

North East Hampshire and Farnham Clinical Commissioning Group Safeguarding Framework North East Hampshire and Farnham Clinical Commissioning Group Safeguarding Framework North East Hampshire and Farnham Clinical Commissioning Group Safeguarding Strategic Framework Page 3 of 27 Contents

More information

Course of Study for the Certification of Competence in Administering Intravenous Injections

Course of Study for the Certification of Competence in Administering Intravenous Injections R A D I O G R A P H Y Course of Study for the Certification of Competence in Administering Intravenous Injections 1 2 Course of Study for the Certification of Competence in Administering Intravenous Injections

More information

Report of a Scoping Exercise for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO)

Report of a Scoping Exercise for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO) Continuity of Care Report of a Scoping Exercise for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO) Summer 2000 prepared by George Freeman and Sasha Shepperd

More information

Standards for the initial education and training of pharmacy technicians. October 2017

Standards for the initial education and training of pharmacy technicians. October 2017 Standards for the initial education and training of pharmacy technicians October 2017 The text of this document (but not the logo and branding) may be reproduced free of charge in any format or medium,

More information

Yorkhill Children s Charity Research Strategy

Yorkhill Children s Charity Research Strategy Yorkhill Children s Charity Research Strategy 1. Objectives Yorkhill Children s Charity provides and supports excellence in paediatric, obstetric and neonatal healthcare enhancing the treatment, care and

More information

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company

More information

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead: Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of

More information

Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6

Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6 The guidelines manual Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course

More information

Foundation in Paediatric Pharmaceutical Care 5th International Masterclass

Foundation in Paediatric Pharmaceutical Care 5th International Masterclass Leading the field in paediatric courses for pharmacists Foundation in Paediatric Pharmaceutical Care 5th International Masterclass 15-17 October 2015 Evelina London Children s Hospital Guy s and St Thomas

More information

Section 2: Advanced level nursing practice competencies

Section 2: Advanced level nursing practice competencies Advanced Level Nursing Practice Section 2: Advanced level nursing practice competencies RCN Standards for advanced level nursing practice, advanced nurse practitioners, RCN accreditation and RCN credentialing

More information

Issue date: October Guide to the multiple technology appraisal process

Issue date: October Guide to the multiple technology appraisal process Issue date: October 2009 Guide to the multiple technology appraisal process Guide to the multiple technology appraisal process Issued: October 2009 This document is one of a series describing the processes

More information

National Institute for Health and Clinical Excellence. The guidelines manual

National Institute for Health and Clinical Excellence. The guidelines manual National Institute for Health and Clinical Excellence The guidelines manual January 2009 The guidelines manual About this document This document describes the methods used in the development of NICE guidelines.

More information

Quality and Safety Committee Terms of Reference

Quality and Safety Committee Terms of Reference Approved May 2016 Quality and Safety Committee Terms of Reference 1. Constitution The Quality and Safety Committee is established as a sub-committee of The Hillingdon Hospitals NHS Foundation Trust (THH)

More information

Education and Training Committee, 5 June 2014

Education and Training Committee, 5 June 2014 Education and Training Committee, 5 June 2014 Directive 2013/55/EU the revised Recognition of Professional Qualifications (RPQ) Directive challenges and opportunities for the Health and Care Professions

More information

MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY

MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt

More information

GUIDANCE ON SUPPORTING INFORMATION FOR REVALIDATION FOR SURGERY

GUIDANCE ON SUPPORTING INFORMATION FOR REVALIDATION FOR SURGERY ON SUPPORTING INFORMATION FOR REVALIDATION FOR SURGERY Based on the Academy of Medical Royal Colleges and Faculties Core Guidance for all doctors GENERAL INTRODUCTION JUNE 2012 The purpose of revalidation

More information

ALLOCATION OF RESOURCES POLICY FOR CONTINUING HEALTHCARE FUNDED INDIVIDUALS

ALLOCATION OF RESOURCES POLICY FOR CONTINUING HEALTHCARE FUNDED INDIVIDUALS ALLOCATION OF RESOURCES POLICY FOR CONTINUING HEALTHCARE FUNDED INDIVIDUALS APPROVED BY: South Gloucestershire Clinical Commissioning Group Quality and Governance Committee DATE Date of Issue:- Version

More information

POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE

POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE POLICY ON THE IMPLEMENTATION OF NICE GUID ANCE Document Type Corporate Policy Unique Identifier CO-019 Document Purpose To outline the process for the implementation and compliance with NICE guidance and

More information

Medical Devices Management Policy

Medical Devices Management Policy Document Author Written By: Medical Devices Co-ordinator Date: 07/02/17 Lead Director: Exectuve Director of Nursing & Quality Authorised Authorised By: Chief Executive Date: 11/04/2017 Effective Date:

More information

Supporting information for appraisal and revalidation: guidance for psychiatry

Supporting information for appraisal and revalidation: guidance for psychiatry Supporting information for appraisal and revalidation: guidance for psychiatry Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose of revalidation

More information

Document Title: Document Number:

Document Title: Document Number: including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate

More information

Health Research 2017 Call for Proposals. Evaluation process guide

Health Research 2017 Call for Proposals. Evaluation process guide Health Research 2017 Call for Proposals Evaluation process guide Evaluation process guide Health Research 2017 Call for Proposals la Caixa Foundation 0 0 Introduction This guide sets out the procedure

More information

Section Title. Prescribing competency framework Catherine Picton, Lead author

Section Title. Prescribing competency framework Catherine Picton, Lead author Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to

More information

Independent Group Advising (NHS Digital) on the Release of Data (IGARD)

Independent Group Advising (NHS Digital) on the Release of Data (IGARD) Document filename: Independent Group Advising (NHS Digital) on the Release of Data (IGARD) Directorate / Programme IGSA Project IGARD Document Reference Status Final Owner Martin Severs Version 1.6 Author

More information

Foundation in Paediatric Pharmaceutical Care 6th International Masterclass

Foundation in Paediatric Pharmaceutical Care 6th International Masterclass Leading the field in paediatric courses Foundation in Paediatric Pharmaceutical Care 6th International Masterclass London, UK Sponsored by In collaboration with 1 Course details Dates Venues: Day 1: Thursday

More information

Are you responding as an individual or on behalf of an organisation?

Are you responding as an individual or on behalf of an organisation? Response form Address: 407 St John Street, London, EC1V 4AD Are you responding as an individual or on behalf of an organisation? If as an individual, are you responding as: a) a doctor? b) a patient? c)

More information

Council, 25 September 2014

Council, 25 September 2014 Council, 25 September 2014 Directive 2013/55/EU the revised Recognition of Professional Qualifications (RPQ) Directive challenges and opportunities for the Health and Care Professions Council (HCPC) Executive

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

Review Date: 6/22/17. Page 1 of 5

Review Date: 6/22/17. Page 1 of 5 Subject: Evaluation of New and Existing Technologies (UM 10) Original Effective Date: 4/24/07 Molina Clinical Policy (MCP)Number: Revision Date(s): 11/20/08, 1/28,09,1/14/10,3/11/10, MCP-000 2/10/2011,

More information

Clinical Development Process 2017

Clinical Development Process 2017 InterQual Clinical Development Process 2017 InterQual Overview Thousands of people in hospitals, health plans, and government agencies use InterQual evidence-based clinical decision support content to

More information

Supporting information for appraisal and revalidation: guidance for pharmaceutical medicine

Supporting information for appraisal and revalidation: guidance for pharmaceutical medicine Supporting information for appraisal and revalidation: guidance for pharmaceutical medicine Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose

More information

G-I-N 2016 conference report

G-I-N 2016 conference report G-I-N 2016 conference report Olena Lishchyshyna was one of the 2016 LMIC conference participation support grant recipients. Below is an account of her experience at G-I-N 2016 and what she gained from

More information

Consultation on developing our approach to regulating registered pharmacies

Consultation on developing our approach to regulating registered pharmacies Consultation on developing our approach to regulating registered pharmacies May 2018 The text of this document (but not the logo and branding) may be reproduced free of charge in any format or medium,

More information

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy

More information

Leadership and management for all doctors

Leadership and management for all doctors Leadership and management for all doctors The duties of a doctor registered with the General Medical Council Patients must be able to trust doctors with their lives and health. To justify that trust you

More information

Document Details Clinical Audit Policy

Document Details Clinical Audit Policy Title Document Details Clinical Audit Policy Trust Ref No 1538-31104 Main points this document covers This policy details the responsibilities and processes associated with the Clinical Audit process within

More information

British Cardiovascular Society. Revalidation of cardiologists: Standards and Content of a portfolio for revalidation

British Cardiovascular Society. Revalidation of cardiologists: Standards and Content of a portfolio for revalidation Page 1 of 8 British Cardiovascular Society Revalidation of cardiologists: Standards and Content of a portfolio for revalidation David Hackett Vice-President, Clinical Standards Division August 2009 Introduction:

More information

Driving and Supporting Improvement in Primary Care

Driving and Supporting Improvement in Primary Care Driving and Supporting Improvement in Primary Care 2016 2020 www.healthcareimprovementscotland.org Healthcare Improvement Scotland 2016 First published December 2016 The publication is copyright to Healthcare

More information

Implementation of the right to access services within maximum waiting times

Implementation of the right to access services within maximum waiting times Implementation of the right to access services within maximum waiting times Guidance for strategic health authorities, primary care trusts and providers DH INFORMATION READER BOX Policy HR / Workforce

More information

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES 24 OCTOBER 2011 INTRODUCTION 1. THE EUROPEAN CONTEXT Centres of expertise (CE) and European Reference

More information

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED

More information

Membership of Alcohol use disorders clinical guideline updates standing committee

Membership of Alcohol use disorders clinical guideline updates standing committee Membership of Alcohol use disorders clinical guideline updates standing committee The Committee will operate as an advisory Committee to NICE s Board, developing clinical guideline updates. The terms of

More information

Scottish Medicines Consortium. A Guide for Patient Group Partners

Scottish Medicines Consortium. A Guide for Patient Group Partners Scottish Medicines Consortium Advising on new medicines for Scotland www.scottishmedicines.org page 1 Acknowledgements Some of the information in this booklet is adapted from guidance produced by the HTAi

More information

NHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF

NHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF NHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF This guidance relates to all staff employed by NHS Fife (including staff within the Health &

More information

Improving the quality of diagnostic spirometry in adults: the National Register of certified professionals and operators

Improving the quality of diagnostic spirometry in adults: the National Register of certified professionals and operators Improving the quality of diagnostic spirometry in adults: the National Register of certified professionals and operators September 2016 Improving the quality of diagnostic spirometry in adults: the National

More information